Drug Development

TM3-4 Peptides Suppress Breast Cancer Growth by Targeting VIPR2 Dimers

Researchers at Hiroshima University will test purified TM3-4 peptides in animal models following cell studies that showed the amino acid sequences disrupt VIPR2 pairing essential for tumor progression.